Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study

Minseok Albert Kim; Seung Up Kim; Dong Hyun Sinn; Jeong Won Jang; Young-Suk Lim; Sang Hoon Ahn; Jae-Jun Shim; Yeon Seok Seo; Yang Hyun Baek; Sang Gyune Kim; Young Seok Kim; Ji Hoon Kim; Won Hyeok Choe; Hyung Joon Yim; Hyun Woong Lee; Jung Hyun Kwon; Sung Won Lee; Jae Young Jang; Hwi Young Kim; Yewan Park; Gi-Ae Kim; Hyun Yang; Han Ah Lee; Myeongseok Koh; Young-Sun Lee; Minkoo Kim; Young Chang; Yoon Jun Kim; Jung-Hwan Yoon; Fabien Zoulim; Jeong-Hoon Lee

doi:10.1136/gutjnl-2019-320015

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Hosted content
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

Hepatology

Original research

Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password